Gordon R. Greenberg

17.0k total citations · 6 hit papers
209 papers, 11.9k citations indexed

About

Gordon R. Greenberg is a scholar working on Genetics, Epidemiology and Molecular Biology. According to data from OpenAlex, Gordon R. Greenberg has authored 209 papers receiving a total of 11.9k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Genetics, 76 papers in Epidemiology and 54 papers in Molecular Biology. Recurrent topics in Gordon R. Greenberg's work include Inflammatory Bowel Disease (78 papers), Microscopic Colitis (55 papers) and Neuropeptides and Animal Physiology (22 papers). Gordon R. Greenberg is often cited by papers focused on Inflammatory Bowel Disease (78 papers), Microscopic Colitis (55 papers) and Neuropeptides and Animal Physiology (22 papers). Gordon R. Greenberg collaborates with scholars based in Canada, United States and United Kingdom. Gordon R. Greenberg's co-authors include Brian G. Feagan, A. Hillary Steinhart, Mark S. Silverberg, Richard N. Fedorak, Gary Wild, Khursheed N. Jeejeebhoy, Stephen B. Hanauer, John WD McDonald, Lloyd R. Sutherland and Elana Maser and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Gordon R. Greenberg

206 papers receiving 11.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

2012 838 citations William J. Sandborn, Paul Rutgeerts et al. profile →
Methotrexate for the Treatment of Crohn's Disease

1995 651 citations Brian G. Feagan, Richard N. Fedorak et al. profile →
Functional variants of OCTN cation transporter genes are associated with Crohn disease

2004 596 citations Gordon R. Greenberg et al. profile →
Treatment of Ulcerative Colitis with a Humanized Antibody to the α ₄ β ₇ Integrin

2005 535 citations Brian G. Feagan, Gordon R. Greenberg et al. profile →
A Comparison of Methotrexate with Placebo for the Maintenance of Remission in Crohn's Disease

2000 530 citations Brian G. Feagan, Richard N. Fedorak et al. profile →
Association of Trough Serum Infliximab to Clinical Outcome After Scheduled Maintenance Treatment for Crohn’s Disease

2006 511 citations Mark S. Silverberg, Gordon R. Greenberg et al. Clinical Gastroenterology and Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gordon R. Greenberg Canada	54	6.8k	5.1k	3.0k	2.3k	2.2k	209	11.9k
Ole Haagen Nielsen Denmark	62	5.9k 0.9×	3.7k 0.7×	3.5k 1.2×	3.5k 1.5×	3.6k 1.6×	342	14.5k
Irving H. Fox United States	45	5.9k 0.9×	5.9k 1.1×	2.2k 0.7×	3.5k 1.5×	2.6k 1.2×	194	12.1k
Richard J. Grand United States	54	4.6k 0.7×	2.5k 0.5×	3.3k 1.1×	1.4k 0.6×	905 0.4×	224	10.1k
Daniël W. Hommes Netherlands	58	5.5k 0.8×	3.7k 0.7×	2.9k 1.0×	2.8k 1.2×	2.9k 1.3×	217	12.6k
Stephan R. Vavricka Switzerland	50	5.4k 0.8×	4.3k 0.8×	3.0k 1.0×	2.2k 0.9×	1.5k 0.7×	240	11.0k
Steven R. Brant United States	47	5.6k 0.8×	3.2k 0.6×	2.9k 1.0×	3.9k 1.7×	3.7k 1.7×	133	11.7k
Claudio Fiocchi United States	64	7.1k 1.0×	3.8k 0.7×	3.8k 1.3×	3.8k 1.7×	5.5k 2.5×	248	15.6k
Iris Dotan Israel	49	5.0k 0.7×	4.2k 0.8×	2.4k 0.8×	1.9k 0.8×	2.0k 0.9×	320	9.5k
Daniel Rachmilewitz Israel	52	13.7k 2.0×	10.5k 2.0×	6.2k 2.1×	2.6k 1.1×	5.2k 2.3×	200	21.5k
Gary Wild Canada	33	5.3k 0.8×	3.8k 0.7×	2.1k 0.7×	644 0.3×	1.7k 0.8×	144	7.7k

Countries citing papers authored by Gordon R. Greenberg

Since Specialization

Citations

This map shows the geographic impact of Gordon R. Greenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon R. Greenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon R. Greenberg more than expected).

Fields of papers citing papers by Gordon R. Greenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon R. Greenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon R. Greenberg. The network helps show where Gordon R. Greenberg may publish in the future.

Co-authorship network of co-authors of Gordon R. Greenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon R. Greenberg. A scholar is included among the top collaborators of Gordon R. Greenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon R. Greenberg. Gordon R. Greenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khanna, Reena, Brian Bressler, Barrett G. Levesque, et al.. (2015). Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial. The Lancet. 386(10006). 1825–1834. 302 indexed citations

Casteele, Niels Vande, Reena Khanna, Barrett G. Levesque, et al.. (2014). The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease. Gut. 64(10). 1539–1545. 224 indexed citations

Ben‐Bassat, Ofer, et al.. (2013). Tu1150 Association of Serum Infliximab and Antibodies to Infliximab to Long-Term Clinical Outcome and Mucosal Healing in Crohn's Disease. Gastroenterology. 144(5). S–775. 11 indexed citations

Waterman, Matti, Wei Xu, Amreen Dinani, et al.. (2012). Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease. Gut. 62(3). 387–394. 93 indexed citations

Feagan, Brian G., Gordon R. Greenberg, Gary Wild, et al.. (2008). Treatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin. Clinical Gastroenterology and Hepatology. 6(12). 1370–1377. 227 indexed citations

Feagan, Brian G., Gordon R. Greenberg, Gary Wild, et al.. (2003). A RANDOMIZED CONTROLLED TRIAL OF A HUMANIZED ALPHA4BETA7 ANTIBODY IN ULCERATIVE COLITIS (UC). The American Journal of Gastroenterology. 98. S248–S249. 4 indexed citations

Brubaker, Patricia L., Daniel J. Drucker, L. Sylvia, et al.. (2002). Prolonged Gastrointestinal Transit in a Patient with a Glucagon-Like Peptide (GLP)-1- and -2-Producing Neuroendocrine Tumor. The Journal of Clinical Endocrinology & Metabolism. 87(7). 3078–3083. 28 indexed citations

Steinhart, A. Hillary, Brian G. Feagan, Cindy J. Wong, et al.. (2002). Combined budesonide and antibiotic therapy for active Crohn's disease: A randomized controlled trial. Gastroenterology. 123(1). 33–40. 157 indexed citations

Toner, Brenda B., Robert Maunder, Gordon R. Greenberg, et al.. (2001). Concerns of patients with inflammatory bowel disease: results from a clinical population. The American Journal of Gastroenterology. 96(6). 1816–1821. 112 indexed citations

10.

Brubaker, Patricia L., et al.. (1998). Nutrient and Peptide Regulation of Somatostatin-28 Secretion from Intestinal Cultures¹. Endocrinology. 139(1). 148–155. 8 indexed citations

11.

Maunder, Robert, William J. Lancee, Mary Jane Esplen, & Gordon R. Greenberg. (1998). Improvement in inflammatory bowel disease-related quality of life, days off work and somatization associated with group psychotherapy. Gastroenterology. 114. A1034–A1034. 3 indexed citations

12.

Greenberg, Gordon R., et al.. (1996). Cellular pathways acting along the germband and in the amnioserosa may participate in germband retraction of the Drosophila melanogaster embryo. The International Journal of Developmental Biology. 40(5). 1043–1051. 11 indexed citations

13.

Brubaker, P. L., Daniel J. Drucker, & Gordon R. Greenberg. (1990). Synthesis and secretion of somatostatin-28 and -14 by fetal rat intestinal cells in culture. American Journal of Physiology-Gastrointestinal and Liver Physiology. 258(6). G974–G981. 13 indexed citations

14.

Strack, Thomas, Gordon R. Greenberg, K. S. Polonsky, & A. M. Albisser. (1990). The effect of a time delay on the characteristics of the canine glucoregulatory system. Metabolism. 39(12). 1219–1224. 2 indexed citations

15.

Greenberg, Gordon R., A.M.J. Buchan, Robin S. McLeod, Peter Preston, & Z. Cohen. (1989). Gut hormone responses after reconstructive surgery for ulcerative colitis.. Gut. 30(12). 1721–1730. 12 indexed citations

16.

McCloy, R F, Gordon R. Greenberg, & J. H. Baron. (1984). Duodenal pH in health and duodenal ulcer disease: effect of a meal, Coca-Cola, smoking, and cimetidine.. Gut. 25(4). 386–392. 86 indexed citations

17.

Adrian, Thomas E., Gordon R. Greenberg, H S Besterman, & Stephen R. Bloom. (1978). Pharmacokinetics of pancreatic polypeptide in man.. Gut. 19(10). 907–909. 61 indexed citations

18.

Sircus, W., G Holdstock, Martin Wiseman, et al.. (1978). The British Society of Gastroenterology. Gut. 19(10). A955–A998. 1 indexed citations

19.

Greenberg, Gordon R., R F McCloy, Thomas E. Adrian, et al.. (1978). Investigation of a physiological role for pancreatic polypeptide (PP) in man. 49. 68. 5 indexed citations

20.

Greenberg, Gordon R. & Ronald L. Somerville. (1962). DEOXYURIDYLATE KINASE ACTIVITY AND DEOXYURIDINETRIPHOSPHATASE IN ESCHERICHIA COLI. Proceedings of the National Academy of Sciences. 48(2). 247–257. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact